Exenatide

Results: 209



#Item
21Microsoft Wordliraglutide NovoNordisk  PSD MArch 2013 final.doc

Microsoft Wordliraglutide NovoNordisk PSD MArch 2013 final.doc

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 21:56:23
22Medication Guide BYDUREON® (by-DUR-ee-on) (exenatide extended-release) for injectable suspension Read this Medication Guide before you start using BYDUREON and each time you get a refill. There may be new information. T

Medication Guide BYDUREON® (by-DUR-ee-on) (exenatide extended-release) for injectable suspension Read this Medication Guide before you start using BYDUREON and each time you get a refill. There may be new information. T

Add to Reading List

Source URL: www.azpicentral.com

Language: English - Date: 2015-03-11 14:26:49
23Stakeholder Forum Summary Stage 3: Type 2 Diabetes Medicines Post-Market Review of Products used in the Management of Diabetes Department of Health, 12 September 2013 This document is intended to provide a broad summary

Stakeholder Forum Summary Stage 3: Type 2 Diabetes Medicines Post-Market Review of Products used in the Management of Diabetes Department of Health, 12 September 2013 This document is intended to provide a broad summary

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2014-10-01 22:38:55
24Submission to the PBAC Post Market Review of Products Used in the Management of Diabetes: Drug Utilisation and Listing Review Boehringer Ingelheim welcomes the opportunity to comment on the Post-Market Review of Products

Submission to the PBAC Post Market Review of Products Used in the Management of Diabetes: Drug Utilisation and Listing Review Boehringer Ingelheim welcomes the opportunity to comment on the Post-Market Review of Products

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2014-10-01 22:38:57
25Medication Safety Today Issue 49  The Northern Ireland Medicines Governance Team Newsletter

Medication Safety Today Issue 49 The Northern Ireland Medicines Governance Team Newsletter

Add to Reading List

Source URL: www.medicinesgovernance.hscni.net

Language: English - Date: 2015-03-31 23:18:37
26Type 2 Diabetes review – ToR 4  COMPARATIVE SAFETY AND EFFECTIVENESS OF TYPE 2 DIABETES MEDICINES  FINAL REPORT

Type 2 Diabetes review – ToR 4 COMPARATIVE SAFETY AND EFFECTIVENESS OF TYPE 2 DIABETES MEDICINES FINAL REPORT

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2014-10-09 02:50:10
27BYETTA® (exenatide) Injection

BYETTA® (exenatide) Injection

Add to Reading List

Source URL: www.fda.gov

Language: English
28Table 8(a):Significant drugs (incl Drs bag)-sorted by highest change to Government cost, year end: Jun 2012 to year end: Jun[removed]Section 85 Only  Year ending Jun 2012 Rank Drug  Volume

Table 8(a):Significant drugs (incl Drs bag)-sorted by highest change to Government cost, year end: Jun 2012 to year end: Jun[removed]Section 85 Only Year ending Jun 2012 Rank Drug Volume

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2015-01-19 18:01:26
29HUMAN RESEARCH KEY FACTS Team Diabetes specialists: 9 Other specialists: 3 Allied health staff:

HUMAN RESEARCH KEY FACTS Team Diabetes specialists: 9 Other specialists: 3 Allied health staff:

Add to Reading List

Source URL: www.bakeridi.edu.au

Language: English - Date: 2012-09-16 22:32:10
30Table 8(a):Significant drugs (incl Drs bag)-sorted by highest change to Government cost, year end: Jun 2011 to year end: Jun[removed]Section 85 Only  Year ending Jun 2011 Rank Drug  Year ending Jun 2012

Table 8(a):Significant drugs (incl Drs bag)-sorted by highest change to Government cost, year end: Jun 2011 to year end: Jun[removed]Section 85 Only Year ending Jun 2011 Rank Drug Year ending Jun 2012

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2015-01-19 18:01:25